Previous Close | 1.8000 |
Open | 1.8000 |
Bid | 0.5000 |
Ask | 2.7000 |
Strike | 450.00 |
Expire Date | 2025-01-17 |
Day's Range | 1.8000 - 1.8000 |
Contract Range | N/A |
Volume | |
Open Interest | 230 |
Intuitive Surgical's third-quarter results are likely to reflect solid performance in the company's Instruments & Accessories segment. Improving margins buoy optimism.
Strength in Analytical Instrument and Specialty Diagnostics segments is likely to have driven Thermo Fisher's third-quarter 2024 performance.
Myriad Genetics and Ultima Genomics to explore the latter's sequencing platform for advanced clinical tests in oncology and reproductive genomics.